NCT02288897 2022-01-19
PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
Provectus Pharmaceuticals
Phase 3 Terminated
Provectus Pharmaceuticals
Fondazione Michelangelo
AB Science
French Innovative Leukemia Organisation
SWOG Cancer Research Network